Search
Returning search results with filters:
Remove filter for
Audience: Hospitals
Remove filter for
Category: Drugs
Remove filter for
Issue: Health products
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 24 items.
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
Affected lot may contain particulate matter
RecallHealth product recall | 2022-08-30
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
RecallHealth product recall | 2022-08-22
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
AlertPublic advisory | 2022-08-20
The affected lots may contain glass particles.
RecallHealth product recall | 2022-08-02
Intravenous bag may be leaking in affected lot
RecallHealth product recall | 2022-03-07
Solution bags may be leaking in affected lot.
RecallHealth product recall | 2022-02-28
Elevated reporting rate of hypersensitivity reactions in affected lot.
RecallHealth product recall | 2022-02-23
The assay is out of specification in the affected lot
RecallHealth product recall | 2022-02-23
Impurities could be out of specification in affected lots.
RecallHealth product recall | 2022-02-04
The dissolution is out of specification in the affected lot(s).
RecallHealth product recall | 2022-01-31
Affected lots exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 36-month stability testing timepoint.
RecallHealth product recall | 2022-01-26
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 36-month stability testing timepoint.
RecallHealth product recall | 2022-01-26
Visible particles observed in vials following reconstitution
RecallHealth product recall | 2022-01-17